EA201892031A1 - Замещенные аналоги нуклеозидов для применения в качестве ингибиторов prmt5 - Google Patents
Замещенные аналоги нуклеозидов для применения в качестве ингибиторов prmt5Info
- Publication number
- EA201892031A1 EA201892031A1 EA201892031A EA201892031A EA201892031A1 EA 201892031 A1 EA201892031 A1 EA 201892031A1 EA 201892031 A EA201892031 A EA 201892031A EA 201892031 A EA201892031 A EA 201892031A EA 201892031 A1 EA201892031 A1 EA 201892031A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- nucleoside analogues
- substituted nucleoside
- prmt5 inhibitors
- compounds
- present
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
Abstract
Настоящее изобретение относится к новым замещенным аналогам нуклеозидов формулы (I), где переменные имеют значения, определенные в формуле изобретения. Соединения в соответствии с настоящим изобретением являются пригодными в качестве ингибиторов PRMT5. Кроме того, настоящее изобретение относится к фармацевтическим композициям, содержащим указанные соединения в качестве активного ингредиента, а также к применению указанных соединений в качестве лекарственного препарата.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662306222P | 2016-03-10 | 2016-03-10 | |
EP16162731 | 2016-03-30 | ||
PCT/EP2017/054324 WO2017153186A1 (en) | 2016-03-10 | 2017-02-24 | Substituted nucleoside analogues for use as prmt5 inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201892031A1 true EA201892031A1 (ru) | 2019-02-28 |
Family
ID=65443152
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201892031A EA201892031A1 (ru) | 2016-03-10 | 2017-02-24 | Замещенные аналоги нуклеозидов для применения в качестве ингибиторов prmt5 |
Country Status (11)
Country | Link |
---|---|
US (1) | US10898504B2 (ru) |
JP (1) | JP6909799B2 (ru) |
BR (1) | BR112018067789B1 (ru) |
EA (1) | EA201892031A1 (ru) |
ES (1) | ES2891320T3 (ru) |
MA (1) | MA43671A (ru) |
MX (1) | MX2018010923A (ru) |
PH (1) | PH12018501895A1 (ru) |
TN (1) | TN2018000310A1 (ru) |
UA (1) | UA123637C2 (ru) |
ZA (1) | ZA201806016B (ru) |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4224438A (en) * | 1970-07-14 | 1980-09-23 | Boehringer Mannheim Gmbh | Adenosine-5'-carboxylic acid amides |
US6143749A (en) | 1995-06-07 | 2000-11-07 | Abbott Laboratories | Heterocyclic substituted cyclopentane compounds |
AU2002351077A1 (en) | 2001-11-05 | 2003-05-19 | Exiqon A/S | Oligonucleotides modified with novel alpha-l-rna analogues |
US7034147B2 (en) * | 2001-11-29 | 2006-04-25 | Irm Llc | Nucleoside analog libraries |
NZ534801A (en) | 2002-02-19 | 2006-04-28 | Cv Therapeutics Inc | Partial and full agonists of A1 adenosine receptors |
US20040043959A1 (en) | 2002-03-04 | 2004-03-04 | Bloom Laura A. | Combination therapies for treating methylthioadenosine phosphorylase deficient cells |
EP1694642A4 (en) | 2003-12-19 | 2010-10-06 | Koronis Pharmaceuticals Inc | MUTAGENIC HETEROCYCLES |
WO2006078752A2 (en) | 2005-01-21 | 2006-07-27 | Methylgene, Inc. | Inhibitors of dna methyltransferase |
US20080132525A1 (en) | 2006-12-04 | 2008-06-05 | Methylgene Inc. | Inhibitors of DNA Methyltransferase |
AU2009298802A1 (en) | 2008-09-23 | 2010-04-08 | Alnylam Pharmaceuticals, Inc. | Chemical modifications of monomers and oligonucleotides with cycloaddition |
BR112012014925A2 (pt) | 2009-12-18 | 2017-03-01 | Joslin Diabetes Center Inc | compostos promotores de replicação de células beta e métodos de uso dos mesmos |
AU2011341441A1 (en) | 2010-12-03 | 2013-06-20 | Epizyme, Inc. | Modulators of histone methyltransferase, and methods of use thereof |
RU2013130253A (ru) | 2010-12-03 | 2015-01-10 | Эпизайм, Инк. | 7-деазапуриновые регуляторы метилтрансферазы гистонов и способы их применения |
WO2012083170A1 (en) | 2010-12-16 | 2012-06-21 | Abbott Laboratories | Anti-viral compounds |
EP2694524B1 (en) | 2011-04-04 | 2016-05-18 | The U.S.A. As Represented By The Secretary, Department Of Health And Human Services | 2'-o-aminooxymethyl nucleoside derivatives for use in the synthesis and modification of nucleosides, nucleotides and oligonucleotides |
US20150057243A1 (en) | 2012-04-02 | 2015-02-26 | Northern University | Compositions and Methods for the Inhibition of Methyltransferases |
WO2014035140A2 (en) | 2012-08-30 | 2014-03-06 | Kainos Medicine, Inc. | Compounds and compositions for modulating histone methyltransferase activity |
US20140100184A1 (en) | 2012-08-31 | 2014-04-10 | Baylor College Of Medicine | Selective inhibitors of histone methyltransferase dot1l |
US8906900B2 (en) | 2012-12-21 | 2014-12-09 | Epizyme, Inc. | PRMT5 inhibitors and uses thereof |
US8940726B2 (en) | 2012-12-21 | 2015-01-27 | Epizyme, Inc. | PRMT5 inhibitors and uses thereof |
JP6678455B2 (ja) | 2012-12-21 | 2020-04-08 | エピザイム,インコーポレイティド | Prmt5阻害剤およびその使用 |
JP6510539B2 (ja) | 2014-01-09 | 2019-05-08 | ザ ジェイ. デヴィッド グラッドストーン インスティテューツ, ア テスタメンタリー トラスト エスタブリッシュド アンダー ザ ウィル オブ ジェイ. デヴィッド グラッドストーン | 置換ベンゾオキサジン及び関連化合物 |
EP3160477A4 (en) | 2014-06-25 | 2018-07-04 | Epizyme, Inc. | Prmt5 inhibitors and uses thereof |
TN2017000357A1 (en) * | 2015-02-24 | 2019-01-16 | Pfizer | Substituted nucleoside derivatives useful as anticancer agents |
TWI791251B (zh) * | 2015-08-26 | 2023-02-01 | 比利時商健生藥品公司 | 使用作為prmt5抑制劑之新穎經6-6雙環芳香環取代之核苷類似物 |
US10685416B2 (en) | 2015-12-10 | 2020-06-16 | Uber Technologies, Inc. | Suggested pickup location for ride services |
KR20180116307A (ko) | 2016-03-10 | 2018-10-24 | 얀센 파마슈티카 엔.브이. | Prmt5 저해제로 사용하기 위한 치환 뉴클레오사이드 유사체 |
EA201990851A1 (ru) | 2017-02-24 | 2019-09-30 | Янссен Фармацевтика Нв | Новые аналоги карбануклеозида, замещенные моноциклической и бициклической кольцевой системой, для применения в качестве ингибиторов prmt5 |
WO2018154104A1 (en) | 2017-02-27 | 2018-08-30 | Janssen Pharmaceutica Nv | Use of biomarkers in identifying cancer patients that will be responsive to treatment with a prmt5 inhibitor |
-
2017
- 2017-02-24 JP JP2018547293A patent/JP6909799B2/ja active Active
- 2017-02-24 TN TNP/2018/000310A patent/TN2018000310A1/en unknown
- 2017-02-24 US US16/082,020 patent/US10898504B2/en active Active
- 2017-02-24 BR BR112018067789-2A patent/BR112018067789B1/pt active IP Right Grant
- 2017-02-24 UA UAA201810095A patent/UA123637C2/uk unknown
- 2017-02-24 EA EA201892031A patent/EA201892031A1/ru unknown
- 2017-02-24 MX MX2018010923A patent/MX2018010923A/es active IP Right Grant
- 2017-02-24 MA MA043671A patent/MA43671A/fr unknown
- 2017-02-24 ES ES17706513T patent/ES2891320T3/es active Active
-
2018
- 2018-09-05 PH PH12018501895A patent/PH12018501895A1/en unknown
- 2018-09-07 ZA ZA2018/06016A patent/ZA201806016B/en unknown
Also Published As
Publication number | Publication date |
---|---|
BR112018067789A2 (pt) | 2019-04-30 |
TN2018000310A1 (en) | 2020-01-16 |
ZA201806016B (en) | 2022-04-28 |
PH12018501895A1 (en) | 2019-05-20 |
ES2891320T3 (es) | 2022-01-27 |
US10898504B2 (en) | 2021-01-26 |
BR112018067789B1 (pt) | 2023-12-12 |
MA43671A (fr) | 2018-11-28 |
JP6909799B2 (ja) | 2021-07-28 |
MX2018010923A (es) | 2019-02-13 |
US20200289539A1 (en) | 2020-09-17 |
UA123637C2 (uk) | 2021-05-05 |
JP2019507778A (ja) | 2019-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201890573A1 (ru) | Новые замещенные 6-6-бициклическим ароматическим кольцом аналоги нуклеозидов для применения в качестве ингибиторов prmt5 | |
EA201990851A1 (ru) | Новые аналоги карбануклеозида, замещенные моноциклической и бициклической кольцевой системой, для применения в качестве ингибиторов prmt5 | |
EA201892734A1 (ru) | ПРОИЗВОДНЫЕ АЗАБЕНЗИМИДАЗОЛА В КАЧЕСТВЕ ИНГИБИТОРОВ pI3K BETA | |
CY1120635T1 (el) | Βενζαμιδια αμινοετεροαρυλιου ως αναστολεις κινασης | |
PH12017501191B1 (en) | Quinazoline derivatives used to treat hiv | |
MY196909A (en) | Boronic acid derivatives and therapeutic uses thereof | |
BR112018003026A2 (pt) | composições compreendendo um inibidor de pi3k e um inibidor de hdac | |
EA201891103A1 (ru) | Композиции для лечения спинальной мышечной атрофии | |
EA201692003A1 (ru) | Макроциклические производные пиримидина | |
EA201692000A1 (ru) | Макроциклические производные пиридина | |
EA202091505A1 (ru) | Триазолазолы циклогексильной кислоты в качестве антагонистов lpa | |
EA201792021A1 (ru) | Ингибитор jak | |
EA201791896A1 (ru) | Дезацетокситубулизин н и его аналоги | |
MX2020005944A (es) | Analogos espirobiciclicos novedosos. | |
PH12019500731A1 (en) | Novel monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as prmt5 inhibitors | |
EA201790570A1 (ru) | Модуляторы р2х7 | |
EA201890906A1 (ru) | ПРОИЗВОДНЫЕ ХИНОКСАЛИНА И ПИРИДОПИРАЗИНА В КАЧЕСТВЕ ИНГИБИТОРОВ PI3Kβ | |
EA201890532A1 (ru) | Новые аннелированные бензамиды | |
EA201691962A1 (ru) | Амидозамещенные азольные соединения в качестве ингибиторов tnks1 и/или tnks2 | |
EA201890534A1 (ru) | Новые аннелированные феноксиацетамиды | |
CY1122381T1 (el) | Παραγωγα ιμιδαζοπυριδαζινης ως αναστολεις pi3kbhta | |
EA201650003A1 (ru) | Соединённые циклоалкилом дигетероциклические производные | |
EA201791397A1 (ru) | СВЯЗАННЫЕ С ГЕТЕРОЦИКЛИЛАМИ ПРОИЗВОДНЫЕ ИМИДАЗОПИРИДАЗИНА В КАЧЕСТВЕ ИНГИБИТОРОВ PI3Kβ | |
EA201990046A1 (ru) | Производные бициклического пиридина, пиразина и пиримидина в качестве ингибиторов pi3k бета | |
EA201892031A1 (ru) | Замещенные аналоги нуклеозидов для применения в качестве ингибиторов prmt5 |